MENU
+Compare
EOLS
Stock ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$11.08
Change
-$0.65 (-5.54%)
Capitalization
846.82M

EOLS Evolus Forecast, Technical & Fundamental Analysis

a manufacturer of neurotoxins

EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for EOLS with price predictions
Dec 17, 2024

Momentum Indicator for EOLS turns negative, indicating new downward trend

EOLS saw its Momentum Indicator move below the 0 level on December 06, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned negative. In of the 92 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for EOLS turned negative on December 12, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EOLS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

EOLS broke above its upper Bollinger Band on November 27, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for EOLS entered a downward trend on November 21, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where EOLS's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EOLS advanced for three days, in of 303 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EOLS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (80.645) is normal, around the industry mean (57.958). P/E Ratio (0.000) is within average values for comparable stocks, (89.727). EOLS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (3.879) is also within normal values, averaging (19.472).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EOLS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EOLS is expected to report earnings to fall 98.67% to 0 cents per share on February 26

Evolus EOLS Stock Earnings Reports
Q4'24
Est.
$0.00
Q3'24
Missed
by $0.18
Q2'24
Missed
by $0.13
Q1'24
Missed
by $0.07
Q4'23
Missed
by $0.09
The last earnings report on November 06 showed earnings per share of -30 cents, missing the estimate of -11 cents. With 317.23K shares outstanding, the current market capitalization sits at 846.82M.
A.I. Advisor
published General Information

General Information

a manufacturer of neurotoxins

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
520 Newport Center Drive
Phone
+1 949 284-4555
Employees
273
Web
https://www.evolus.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CGJIX70.13-0.26
-0.37%
Calvert US Large Cap Growth Rspnb Idx I
AIAFX23.39-0.16
-0.68%
abrdn Global Infrastructure A
BMGCX28.43-0.27
-0.94%
BlackRock Mid-Cap Growth Equity Inv C
FTUTX54.12-0.56
-1.02%
Fidelity Advisor Telecommunications M
GTSRX25.58-0.32
-1.24%
Invesco Small Cap Growth R

EOLS and Stocks

Correlation & Price change

A.I.dvisor tells us that EOLS and AMPH have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EOLS and AMPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EOLS
1D Price
Change %
EOLS100%
+1.91%
AMPH - EOLS
28%
Poorly correlated
+0.02%
ACET - EOLS
26%
Poorly correlated
-0.75%
EVOK - EOLS
26%
Poorly correlated
+0.03%
SNDL - EOLS
25%
Poorly correlated
+4.17%
LFCR - EOLS
23%
Poorly correlated
-3.74%
More